Population
Calcium-activated potassium channels from coronary smooth muscle incorporated into lipid bilayers
Design
Preclinical
Authors
Loading...
Supports direct ANG II vasoconstriction via coronary KCa inhibition; hypothesis-generating in animals, requires human validation.
Angiotensin II directly inhibits calcium-activated potassium channels in coronary smooth muscle, providing a mechanism for its vasoconstrictive effects.
Toro et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: